FDA Inspection 1267697 - Everest Life Sciences LLC - April 23, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Everest Life Sciences LLC

Record Details

This FDA Inspection record concerns Everest Life Sciences LLC, with an inspection on April 23, 2025, issued by the New Jersey District Office, covering human drugs.

Company: Everest Life Sciences LLC
Inspection Date: April 23, 2025
Product Type: Human Drugs
Office: New Jersey District Office

Open in Dashboard

ID · c8c57801-5139-4351-b5c2-5a1ba452bda1

Violation Codes6

21 CFR 211.100(a)21 CFR 211.160(b)21 CFR 211.22(d)21 CFR 211.67(a)21 CFR 211.68(a)21 CFR 211.68(b)

Full citation text and observation details available on the Dashboard.

FDA Inspection

Everest Life Sciences LLCApril 23, 2025